BORR vs NVGS

BORR's Piotroski F-Score of 4/9 indicates borderline financial health, while the absence of an Altman Z-Score prevents a full distress risk assessment. The stock trades below its Graham Number of $5.01 at $4.47, suggesting modest undervaluation, though forward P/E of -47.51 signals expected earnings deterioration. Strong operating and gross margins contrast with high debt/equity of 1.80 and inconsistent earnings growth, particularly the recent Q/Q EPS decline of -35.7%. Technical trend is weak at 10/100, but dividend strength and insider sentiment are below average, contributing to a cautious outlook.

NVGS presents a stark divergence between market price and fundamental performance. While the Piotroski F-Score of 4/9 indicates stable financial health and the Graham Number ($24.94) suggests defensive value, the growth-based intrinsic value ($10.29) is significantly below the current price of $21.80. The company is currently trading at its 52-week high despite negative earnings growth (-10.9% YoY) and a dismal earnings track record, missing 4 of the last 4 estimates. The 'Strong Buy' analyst consensus is not supported by the deterministic scorecard or the negative earnings trajectory.